Clinical Trials Directory

Trials / Unknown

UnknownNCT04330222

Cambridge 7 Tesla Cerebral Small Vessel Disease Study

Imaging the Arterial Pathology in Cerebral Small Vessel Disease Using 7 Tesla Magnetic Resonance Imaging

Status
Unknown
Phase
Study type
Observational
Enrollment
210 (estimated)
Sponsor
University of Cambridge · Academic / Other
Sex
All
Age
18 Years – 99 Years
Healthy volunteers
Accepted

Summary

CamSVD is jointly sponsored by the University of Cambridge and Cambridge University Hospitals NHS Foundation Trust. We aim to explore and understand the underlying arterial pathology in Cerebral Small Vessel Disease (SVD) using ultra-high-field 7 Tesla MRI. We will optimise 7T Time-of-Flight MR angiography, blood suppressed MR sequence and phase-contrast (PC) MR angiography for visualization of perforating lenticulostriate arteries. This optimised sequences will be used to determine the range of arterial pathologies seen in individuals presenting with lacunar strokes. The pathologies of the perforating lenticulostriate arteries will be correlated with conventional clinical risk factors, cognition and radiological markers of SVD.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TEST7 Tesla Magnetic Resonance ImagingDiagnostic Imaging
OTHERBrief Memory and Executive TestCognitive Assessment

Timeline

Start date
2020-03-09
Primary completion
2024-01-12
Completion
2024-01-12
First posted
2020-04-01
Last updated
2022-09-21

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT04330222. Inclusion in this directory is not an endorsement.